CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 91 filers reported holding CUREVAC N V in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $174,001 | -34.5% | 25,476 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $265,460 | +132.0% | 25,476 | +55.2% | 0.00% | 0.0% |
Q1 2023 | $114,433 | +8.8% | 16,418 | -5.9% | 0.00% | 0.0% |
Q4 2022 | $105,175 | +59.4% | 17,442 | +107.1% | 0.00% | – |
Q3 2022 | $66,000 | -84.7% | 8,421 | -73.3% | 0.00% | -100.0% |
Q2 2022 | $430,000 | +4.1% | 31,592 | +50.0% | 0.00% | +50.0% |
Q1 2022 | $413,000 | -26.2% | 21,057 | +29.0% | 0.00% | -33.3% |
Q4 2021 | $560,000 | +5.3% | 16,317 | +67.5% | 0.00% | 0.0% |
Q3 2021 | $532,000 | +76.2% | 9,739 | +136.9% | 0.00% | +50.0% |
Q2 2021 | $302,000 | – | 4,111 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,625,943 | $11,332,823 | 10.01% |
RA Capital Management | 12,245,955 | $85,354,306 | 1.93% |
Avidity Partners Management LP | 3,550,000 | $24,743,500 | 0.82% |
Camber Capital Management LP | 1,250,000 | $8,713 | 0.27% |
Ghisallo Capital Management LLC | 100,000 | $697,000 | 0.17% |
FOX RUN MANAGEMENT, L.L.C. | 31,278 | $218,008 | 0.07% |
Alyeska Investment Group, L.P. | 1,060,382 | $7,390,863 | 0.06% |
Green Alpha Advisors, LLC | 12,351 | $86,086 | 0.06% |
Virtus ETF Advisers LLC | 14,114 | $98,375 | 0.05% |
Quantamental Technologies LLC | 11,146 | $77,688 | 0.04% |